Home
→
Browsing by Author

Browsing by Author "Cervantes, Andrés"

Now showing items 1-5 of 5

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer

Cejalvo, Juan M.; Jacob, Wolfgang; Fleitas Kanonnikoff, Tania; Felip, Enriqueta; Navarro Mendivil, Alejandro; Martínez-García, Maria; Taus García, Álvaro; Leighl, Natasha; Lassen, Ulrik; Mau-Soerensen, Morten; Adessi, Celine; Michielin, Francesca; James, Ian; Ceppi, Maurizio; Hasmann, Max; Weisser, Martin; Cervantes, Andrés (BMJ Publishing Group, 2019)

PURPOSE:This study investigated the safety and clinical activity of lumretuzumab, a humanised antihuman epidermal growth factor receptor 3 (HER3) monoclonal antibody, in combination with carboplatin and paclitaxel in ...
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer

Tarazona, Noelia; Calon, Alexandre; Cervantes, Andrés (Elsevier, 2020)

Background: Colon cancer (CC) is a heterogeneous disease. Novel prognostic factors beyond pathological staging are required to accurately identify patients at higher risk of relapse. Integrating these new biological factors, ...
In the literature: december 2021

Montagut Viladot, Clara; Gambardella, V.; Cabeza-Segura, M.; Fleitas Kanonnikoff, Tania; Cervantes, Andrés (Elsevier, 2021)
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer

Schneeweiss, Andreas; Albanell Mestres, Joan; Cervantes, Andrés (Springer, 2018)

Purpose To investigate the safety and clinical activity of comprehensive human epidermal growth factor receptor (HER) family receptor inhibition using lumretuzumab (anti-HER3) and pertuzumab (anti-HER2) in combination with ...
The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice

Badia-Ramentol, Jordi; Gimeno-Valiente, Francisco; Duréndez, Elena; Martínez-Ciarpaglini, Carolina; Linares Aceituno, Jenniffer Lissethe; Iglesias Coma, Mar; Cervantes, Andrés; Calon, Alexandre; Tarazona, Noelia (Elsevier, 2023)

Adjuvant chemotherapy following surgical intervention remains the primary treatment option for patients with localized colorectal cancer (CRC). However, a significant proportion of patients will have an unfavorable outcome ...

Now showing items 1-5 of 5

Search DSpace

Advanced Search

Browse

All of DSpace

My Account

In collaboration with Compliant to Partaking

Browsing by Author "Cervantes, Andrés"

Browsing by Author "Cervantes, Andrés"

Search DSpace

Browse

All of DSpace

My Account